Thalidomide-piperazine-Boc
| Code | Size | Price |
|---|
| TAR-T39697-100mg | 100mg | £204.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Thalidomide-piperazine-Boc is an intermediate that can be used in the synthesis of B-cell lymphoma 6 protein (BCL6) PROTAC.
CAS:
2222114-64-7
Formula:
C22H26N4O6
Molecular Weight:
442.472
Purity:
0.98
SMILES:
CC(C)(C)OC(=O)N1CCN(CC1)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1
References
Michael Berlin, et al. Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety. WO2021077010A1.